{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T12:05:27Z","timestamp":1765713927876,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia, Portugal","award":["EU JPND project SOPHIA (JPND\/0003\/2011)","Euronanomed 2 ERA-NET project GlioEx (ENMed\/0001\/2013)"],"award-info":[{"award-number":["EU JPND project SOPHIA (JPND\/0003\/2011)","Euronanomed 2 ERA-NET project GlioEx (ENMed\/0001\/2013)"]}]},{"name":"FCT \/ Minist\u00e9rio da Ci\u00eancia e do Ensino Superior, Portugal","award":["iNOVA4Health Research Unit (LISBOA-01-0145-FEDER-007344)"],"award-info":[{"award-number":["iNOVA4Health Research Unit (LISBOA-01-0145-FEDER-007344)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12035-019-1482-9","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T01:02:37Z","timestamp":1562547757000},"page":"5729-5739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7782-6319","authenticated-orcid":false,"given":"Julia","family":"Costa","sequence":"first","affiliation":[]},{"given":"Linda","family":"Streich","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Pronto-Laborinho","sequence":"additional","affiliation":[]},{"given":"Manfred","family":"Nimtz","sequence":"additional","affiliation":[]},{"given":"Harald S.","family":"Conradt","sequence":"additional","affiliation":[]},{"given":"Mamede","family":"de Carvalho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"1482_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/jnnp-2016-314495","volume":"88","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Brayne C, Beghi E, van den Berg LH, Chio A, Martin S et al (2017) The changing picture of amyotrophic lateral sclerosis: lessons from European registers. J Neurol Neurosurg Psychiatry 88:557\u2013563. \n                    https:\/\/doi.org\/10.1136\/jnnp-2016-314495","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1482_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/17482960701553956","volume":"8","author":"LO Gouveia","year":"2007","unstructured":"Gouveia LO, de Carvalho M (2007) Young-onset sporadic amyotrophic lateral sclerosis: a distinct nosological entity? Amyotroph Lateral Scler 8:323\u2013327. \n                    https:\/\/doi.org\/10.1080\/17482960701553956","journal-title":"Amyotroph Lateral Scler"},{"key":"1482_CR3","doi-asserted-by":"publisher","first-page":"764","DOI":"10.2174\/187152710793237502","volume":"9","author":"J Costa","year":"2010","unstructured":"Costa J, Gomes C, de Carvalho M (2010) Diagnosis, pathogenesis and therapeutic targets in amyotrophic lateral sclerosis. CNS Neurol Disord Drug Targets 9:764\u2013778","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1482_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1474-4422(13)70036-X","volume":"12","author":"MR Turner","year":"2013","unstructured":"Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C et al (2013) Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol 12:310\u2013322. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(13)70036-X","journal-title":"Lancet Neurol"},{"key":"1482_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/prca.201200067","volume":"7","author":"T Kruger","year":"2013","unstructured":"Kruger T, Lautenschlager J, Grosskreutz J, Rhode H (2013) Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery. Proteomics Clin Appl 7:123\u2013135. \n                    https:\/\/doi.org\/10.1002\/prca.201200067","journal-title":"Proteomics Clin Appl"},{"key":"1482_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cca.2016.01.011","volume":"455","author":"J Costa","year":"2016","unstructured":"Costa J, de Carvalho M (2016) Emerging molecular biomarker targets for amyotrophic lateral sclerosis. Clin Chim Acta 455:7\u201314. \n                    https:\/\/doi.org\/10.1016\/j.cca.2016.01.011","journal-title":"Clin Chim Acta"},{"key":"1482_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3109\/21678421.2014.884592","volume":"15","author":"S Lehnert","year":"2014","unstructured":"Lehnert S, Costa J, de Carvalho M, Kirby J, Kuzma-Kozakiewicz M, Morelli C, Robberecht W, Shaw P et al (2014) Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 15:344\u2013350. \n                    https:\/\/doi.org\/10.3109\/21678421.2014.884592","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"1482_CR8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.cca.2014.09.011","volume":"438","author":"M Goncalves","year":"2015","unstructured":"Goncalves M, Tillack L, de Carvalho M, Pinto S, Conradt HS, Costa J (2015) Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis. Clin Chim Acta 438:342\u2013349. \n                    https:\/\/doi.org\/10.1016\/j.cca.2014.09.011","journal-title":"Clin Chim Acta"},{"key":"1482_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3109\/21678421.2016.1167913","volume":"17","author":"P Oeckl","year":"2016","unstructured":"Oeckl P, Jardel C, Salachas F, Lamari F, Andersen PM, Bowser R, de Carvalho M, Costa J et al (2016) Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS. Amyotroph Lateral Scler Frontotemporal Degener 17:404\u2013413. \n                    https:\/\/doi.org\/10.3109\/21678421.2016.1167913","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"1482_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jnnp-2015-311387","volume":"87","author":"P Steinacker","year":"2016","unstructured":"Steinacker P, Feneberg E, Weishaupt J, Brettschneider J, Tumani H, Andersen PM, von Arnim CA et al (2016) Neurofilaments in the diagnosis of motoneuron diseases: A prospective study on 455 patients. J Neurol Neurosurg Psychiatry 87:12\u201320. \n                    https:\/\/doi.org\/10.1136\/jnnp-2015-311387","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1482_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035772","volume":"7","author":"M Edri-Brami","year":"2012","unstructured":"Edri-Brami M, Rosental B, Hayoun D, Welt M, Rosen H, Wirguin I, Nefussy B, Drory VE et al (2012) Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells. PLoS One 7:e35772. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0035772","journal-title":"PLoS One"},{"key":"1482_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.expneurol.2015.02.023","volume":"267","author":"M Edri-Brami","year":"2015","unstructured":"Edri-Brami M, Sharoni H, Hayoun D, Skutelsky L, Nemirovsky A, Porgador A, Lichtenstein RG (2015) Development of stage-dependent glycans on the Fc domains of IgG antibodies of ALS animals. Exp Neurol 267:95\u2013106. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2015.02.023","journal-title":"Exp Neurol"},{"key":"1482_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","volume":"25","author":"JN Arnold","year":"2007","unstructured":"Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA (2007) The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 25:21\u201350. \n                    https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141702","journal-title":"Annu Rev Immunol"},{"key":"1482_CR14","unstructured":"Thompson E J (2005) Proteins of the cerebrospinal fluid 2nd edition London: Elsevier :p.16."},{"key":"1482_CR15","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1074\/mcp.O116.058503","volume":"15","author":"R Plomp","year":"2016","unstructured":"Plomp R, Bondt A, de Haan N, Rombouts Y, Wuhrer M (2016) Recent advances in clinical glycoproteomics of immunoglobulins (Igs). Mol Cell Proteomics 15:2217\u20132228. \n                    https:\/\/doi.org\/10.1074\/mcp.O116.058503","journal-title":"Mol Cell Proteomics"},{"issue":"235","key":"1482_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12974-015-0450-1","volume":"12","author":"M Wuhrer","year":"2015","unstructured":"Wuhrer M, Selman MH, McDonnell LA, Kumpfel T, Derfuss T, Khademi M, Olsson T et al (2015) Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. J Neuroinflammation 12(235):235. \n                    https:\/\/doi.org\/10.1186\/s12974-015-0450-1","journal-title":"J Neuroinflammation"},{"key":"1482_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jneuroim.2018.04.010","volume":"320","author":"J Knopf","year":"2018","unstructured":"Knopf J, Magorivska I, Maler JM, Spitzer P, Bilyy R, Biermann MHC, Hychka K, Bondt A et al (2018) Low amounts of bisecting glycans characterize cerebrospinal fluid-borne IgG. J Neuroimmunol 320:19\u201324. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2018.04.010","journal-title":"J Neuroimmunol"},{"key":"1482_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D (2000) El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293\u2013299","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"1482_CR19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3109\/21678421.2016.1140786","volume":"17","author":"M Proudfoot","year":"2016","unstructured":"Proudfoot M, Jones A, Talbot K, Al-Chalabi A, Turner MR (2016) The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset. Amyotroph Lateral Scler Frontotemporal Degener 17:414\u2013425. \n                    https:\/\/doi.org\/10.3109\/21678421.2016.1140786","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"1482_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1006\/abio.1995.1468","volume":"230","author":"JC Bigge","year":"1995","unstructured":"Bigge JC, Patel TP, Bruce JA, Goulding PN, Charles SM, Parekh RB (1995) Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal Biochem 230:229\u2013238. \n                    https:\/\/doi.org\/10.1006\/abio.1995.1468","journal-title":"Anal Biochem"},{"key":"1482_CR21","doi-asserted-by":"publisher","first-page":"7871","DOI":"10.1021\/acs.analchem.7b05455","volume":"90","author":"J Costa","year":"2018","unstructured":"Costa J, Gatermann M, Nimtz M, Kandzia S, Glatzel M, Conradt HS (2018) N-glycosylation of extracellular vesicles from HEK-293 and glioma cell lines. Anal Chem 90:7871\u20137879. \n                    https:\/\/doi.org\/10.1021\/acs.analchem.7b05455","journal-title":"Anal Chem"},{"key":"1482_CR22","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1021\/pr7008252","volume":"7","author":"A Ceroni","year":"2008","unstructured":"Ceroni A, Maass K, Geyer H, Geyer R, Dell A, Haslam SM (2008) GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. J Proteome Res 7:1650\u20131659. \n                    https:\/\/doi.org\/10.1021\/pr7008252","journal-title":"J Proteome Res"},{"key":"1482_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/21678421.2016.1212894","volume":"18","author":"M Goncalves","year":"2017","unstructured":"Goncalves M, De Carvalho M, Peixoto C, Alves P, Barreto C, Oliva A, Pinto S et al (2017) Phosphoneurofilament heavy chain and vascular endothelial growth factor as cerebrospinal fluid biomarkers for ALS. Amyotroph Lateral Scler Frontotemporal Degener 18:134\u2013136. \n                    https:\/\/doi.org\/10.1080\/21678421.2016.1212894","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"1482_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.arr.2012.02.002","volume":"12","author":"F Dall'Olio","year":"2013","unstructured":"Dall'Olio F, Vanhooren V, Chen CC, Slagboom PE, Wuhrer M, Franceschi C (2013) N-glycomic biomarkers of biological aging and longevity: a link with inflammaging. Ageing Res Rev 12:685\u2013698. \n                    https:\/\/doi.org\/10.1016\/j.arr.2012.02.002","journal-title":"Ageing Res Rev"},{"key":"1482_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/jnnp-2014-309964","volume":"87","author":"AH Wong","year":"2016","unstructured":"Wong AH, Fukami Y, Sudo M, Kokubun N, Hamada S, Yuki N (2016) Sialylated IgG-Fc: A novel biomarker of chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 87:275\u2013279. \n                    https:\/\/doi.org\/10.1136\/jnnp-2014-309964","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1482_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrrheum.2017.146","volume":"13","author":"M Seeling","year":"2017","unstructured":"Seeling M, Bruckner C, Nimmerjahn F (2017) Differential antibody glycosylation in autoimmunity: Sweet biomarker or modulator of disease activity? Nat Rev Rheumatol 13:621\u2013630. \n                    https:\/\/doi.org\/10.1038\/nrrheum.2017.146","journal-title":"Nat Rev Rheumatol"},{"key":"1482_CR27","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/glycob\/cwv065","volume":"25","author":"D Reusch","year":"2015","unstructured":"Reusch D, Tejada ML (2015) Fc glycans of therapeutic antibodies as critical quality attributes. Glycobiology 25:1325\u20131334. \n                    https:\/\/doi.org\/10.1093\/glycob\/cwv065","journal-title":"Glycobiology"},{"key":"1482_CR28","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s11064-010-0156-9","volume":"35","author":"SD Sussmuth","year":"2010","unstructured":"Sussmuth SD, Sperfeld AD, Ludolph AC, Tumani H (2010) Hypercapnia is a possible determinant of the function of the blood-cerebrospinal fluid barrier in amyotrophic lateral sclerosis. Neurochem Res 35:1071\u20131074. \n                    https:\/\/doi.org\/10.1007\/s11064-010-0156-9","journal-title":"Neurochem Res"},{"key":"1482_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00415-012-6589-0","volume":"260","author":"N Ticozzi","year":"2013","unstructured":"Ticozzi N, Tiloca C, Mencacci NE, Morelli C, Doretti A, Rusconi D, Colombrita C, Sangalli D et al (2013) Oligoclonal bands in the cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated mutations. J Neurol 260:85\u201392. \n                    https:\/\/doi.org\/10.1007\/s00415-012-6589-0","journal-title":"J Neurol"},{"issue":"564\u2013577","key":"1482_CR30","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1016\/j.cell.2017.11.041","volume":"172","author":"JD Pagan","year":"2018","unstructured":"Pagan JD, Kitaoka M, Anthony RM (2018) Engineered sialylation of pathogenic antibodies in vivo attenuates autoimmune disease. Cell 172(564\u2013577):e513. \n                    https:\/\/doi.org\/10.1016\/j.cell.2017.11.041","journal-title":"Cell"},{"key":"1482_CR31","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/nm.2862","volume":"18","author":"CM Karsten","year":"2012","unstructured":"Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M, McDonald JU, Orr SJ et al (2012) Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1. Nat Med 18:1401\u20131406. \n                    https:\/\/doi.org\/10.1038\/nm.2862","journal-title":"Nat Med"},{"key":"1482_CR32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/316452a0","volume":"316","author":"RB Parekh","year":"1985","unstructured":"Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, Rademacher TW, Mizuochi T et al (1985) Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316:452\u2013457","journal-title":"Nature"},{"key":"1482_CR33","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.bbagen.2005.11.021","volume":"1760","author":"M Holland","year":"2006","unstructured":"Holland M, Yagi H, Takahashi N, Kato K, Savage CO, Goodall DM, Jefferis R (2006) Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim Biophys Acta 1760:669\u2013677. \n                    https:\/\/doi.org\/10.1016\/j.bbagen.2005.11.021","journal-title":"Biochim Biophys Acta"},{"key":"1482_CR34","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.4049\/jimmunol.1502136","volume":"196","author":"FS Bovenkamp van de","year":"2016","unstructured":"van de Bovenkamp FS, Hafkenscheid L, Rispens T, Rombouts Y (2016) The emerging importance of IgG Fab glycosylation in immunity. J Immunol 196:1435\u20131441. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1502136","journal-title":"J Immunol"},{"key":"1482_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1021\/pr1004373","volume":"10","author":"MH Selman","year":"2011","unstructured":"Selman MH, Niks EH, Titulaer MJ, Verschuuren JJ, Wuhrer M, Deelder AM (2011) IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis. J Proteome Res 10:143\u2013152. \n                    https:\/\/doi.org\/10.1021\/pr1004373","journal-title":"J Proteome Res"},{"key":"1482_CR36","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1177\/1352458516631036","volume":"22","author":"Y Decker","year":"2016","unstructured":"Decker Y, Schomburg R, Nemeth E, Vitkin A, Fousse M, Liu Y, Fassbender K (2016) Abnormal galactosylation of immunoglobulin G in cerebrospinal fluid of multiple sclerosis patients. Mult Scler 22:1794\u20131803. \n                    https:\/\/doi.org\/10.1177\/1352458516631036","journal-title":"Mult Scler"},{"key":"1482_CR37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM (2016) How neuroinflammation contributes to neurodegeneration. Science 353:777\u2013783. \n                    https:\/\/doi.org\/10.1126\/science.aag2590","journal-title":"Science"},{"key":"1482_CR38","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140:918\u2013934. \n                    https:\/\/doi.org\/10.1016\/j.cell.2010.02.016","journal-title":"Cell"},{"key":"1482_CR39","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mus.10191","volume":"26","author":"PL McGeer","year":"2002","unstructured":"McGeer PL, McGeer EG (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26:459\u2013470. \n                    https:\/\/doi.org\/10.1002\/mus.10191","journal-title":"Muscle Nerve"},{"key":"1482_CR40","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1172\/JCI90607","volume":"127","author":"D Lall","year":"2017","unstructured":"Lall D, Baloh RH (2017) Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J Clin Invest 127:3250\u20133258. \n                    https:\/\/doi.org\/10.1172\/JCI90607","journal-title":"J Clin Invest"},{"key":"1482_CR41","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/glycob\/cwx022","volume":"27","author":"AC Russell","year":"2017","unstructured":"Russell AC, Simurina M, Garcia MT, Novokmet M, Wang Y, Rudan I, Campbell H et al (2017) The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson\u2019s disease. Glycobiology 27:501\u2013510. \n                    https:\/\/doi.org\/10.1093\/glycob\/cwx022","journal-title":"Glycobiology"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1482-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-1482-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1482-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T19:30:01Z","timestamp":1579721401000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-1482-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1482"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-1482-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"type":"print","value":"0893-7648"},{"type":"electronic","value":"1559-1182"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"assertion":[{"value":"26 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patients signed permission for biobank storage, and further studies were agreed by the local Ethic\u2019s committee. The research was done in accordance with the Helsinki Declaration as revised in 2013 (www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}